Prodromal Markers in Recurrent Dream Enactment Behaviors Without REM Sleep Without Atonia
Striatal Dopamine Transmission and Prodromal Markers of α-synucleinopathy Neurodegeneration in Recurrent Dream Enactment Behaviors Without REM Sleep Without Atonia: a Case-control Study
1 other identifier
observational
102
1 country
1
Brief Summary
REM sleep behavior disorder is a novel and distinct parasomnia characterized by recurrent dream enactment behaviors (DEBs) and REM sleep without atonia (RSWA) during polysomnographic assessment, with a male predominance and typical onset age at early 60's. The majority of patients with idiopathic RBD (iRBD) will eventually develop α-synucleinopathy, for instance Parkinson's disease (PD). Thus, iRBD has been considered as a highly specific precursor of α-synucleinopathy-related neurodegeneration. Recently, increasing studies have found that some participants present with only RSWA or DEBs (but without sufficient RSWA), which does not meet the diagnostic criteria for RBD. It has been suggested that these participants with subclinical features (either DEBs or RSWA) might represent a condition known as prodromal RBD. Several emerging evidence, including our own study, have implied a link between isolated RSWA (RSWA without DEBs) and markers of α-synucleinopathy-related neurodegeneration. However, it is still unclear whether the other condition related to RBD, i.e. recurrent DEBs but without sufficient RSWA, is related to a certain degree of α-synucleinopathy. In this regard, the novel concept of recurrent DEBs but without sufficient RSWA, also termed as prodromal/isolated RBD by some researchers, requires validation by further evidence in terms of clinical feature and neurodegenerative prodromal markers perspectives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2021
CompletedStudy Start
First participant enrolled
January 3, 2022
CompletedFirst Posted
Study publicly available on registry
April 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedApril 19, 2024
April 1, 2024
2.5 years
December 21, 2021
April 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Parkinson's Disease
overall probability of prodromal PD based on the MDS research criteria for prodromal PD
1 year
Interventions
No intervention
Eligibility Criteria
The recruiting ability for the current study is further evidenced by a series of studies and publications in the past few years. For example, in our ongoing case-control family study, the investigator have recruited 89 control proband and 64 their FDRs who have all underwent v-PSG (Liu et al, Annals of Neurology 2019). By now, the investigator have expanded the number to 103 control probands and 91 FDRs. The investigator believe that this cohort will help us to recruit sufficient number of control subjects in this proposed study.
You may qualify if:
- Age between 45 and 65 years old
- RBDQ-HK behavior factor greater \> 8
- Recurrent DEBs by interview and/or video analysis
- Absence of sufficient RSWA
You may not qualify if:
- Age- and sex- matched with cases
- RBDQ-HK behavior factor \< 8
- No DEBs by either interview or video analysis
- Absence of sufficient RSWA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shatin Hospital
Shatin, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yun Kwok Wing, Professor
Chinese University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 21, 2021
First Posted
April 29, 2022
Study Start
January 3, 2022
Primary Completion
June 30, 2024
Study Completion
June 30, 2024
Last Updated
April 19, 2024
Record last verified: 2024-04